Two people in US hospitalized with bird flu, CDC reports
Two people, in Wyoming and Ohio, have been hospitalized with H5N1 bird flu, the US Centers for Disease Control and Prevention (CDC) said in a routine flu update on Friday.
The person from Wyoming is still in hospital, while the Ohio patient has been released, according to the report. Both patients experienced 'respiratory and non-respiratory symptoms', the report said, without detailing those symptoms.
'This shows that H5N1 can be very severe and we should not assume that it will always be mild,' said Angela Rasmussen, a virologist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan.
The news comes amid one of the worst seasonal flu outbreaks in 15 years – raising the potential for the emergence of a more dangerous virus that combines bird flu and seasonal flu in a process called reassortment.
'I am very worried about H5N1 in patients that are being treated in hospitals where there are also many seasonal flu patients because this creates opportunities for reassortment, which could potentially produce a pandemic-capable H5N1,' Rasmussen said.
These are the first human H5 cases detected in Wyoming and Ohio.
An 'older' woman from Platte county, Wyoming, was hospitalized in another state, according to a statement from the Wyoming department of health. She 'has health conditions that can make people more vulnerable to illness', the statement says.
The woman was exposed to poultry in a backyard flock that tested positive for H5N1, the CDC report said, adding that she remained hospitalized at the time of the report.
A man in Mercer county, Ohio, was infected while depopulating, or killing, H5N1-positive poultry at a commercial facility, according to a statement from the Ohio department of health.
The man has been discharged from the hospital 'and is now recovering at home', the CDC report said.
So far, there have been 70 confirmed cases of the highly pathogenic avian influenza in the US since it was first detected in cows last year.
There is no evidence of human-to-human transmission at this point. The majority of cases have been among people who have close contact with animals.
Previously, a patient in Missouri was hospitalized and tested positive for bird flu after no known exposure. And a man in Louisiana was hospitalized and died after exposure to backyard chickens and wild birds.
A 13-year-old girl was also extremely ill and in the hospital for months in British Columbia after no known exposure.
The Louisiana and BC cases were both caused by a variant of H5N1 that emerged in the fall and has quickly become dominant in birds – and has now spilled over, separately, into dairy cows in Nevada and Arizona.
The new spillovers come as the Trump administration weighs a strategy that wouldn't seek to contain outbreaks in poultry through depopulation.
The new head of health agencies, Robert F Kennedy Jr, has reportedly stopped a seasonal flu vaccine campaign. A scheduled meeting of the CDC's independent vaccines committee has also been postponed.
A new study, published by the CDC's Emerging Infectious Diseases journal, offers some insight into why some cases may not be as severe as others.
Researchers infected ferrets with H1N1 and then, three months later, infected them with H5N1 or H7N9, a low-pathogenicity variant.
H1N1 was the swine flu responsible for the 2009-10 epidemic. It never went away – in fact, it's one of two seasonal variants behind this year's flu season.
The ferrets with recent H1N1 antibodies were able to neutralize H5N1 more quickly than H7N9, indicating some protectiveness from the previous infection.
Another new study in the same journal found that ferrets first infected with H1N1 had less severe disease from H5N1 – suggesting that some humans may experience the same, the authors wrote.
'This is evidence that prior H1N1 infection or vaccination may provide some level of cross-protection via anti-N1 immunity,' Rasmussen said.
But it's not clear to what degree that protection might help people.
'We shouldn't interpret this to mean protection will be absolute in the human population,' Rasmussen said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
17 hours ago
- Reuters
Texas health department reports no additional measles cases in the state since June 3
June 6 (Reuters) - The Texas health department reported no new cases of measles on Friday, the first time the state has not recorded an increase since the outbreak began in February. The state, which is the epicenter of the current measles outbreak, has a total of 742 confirmed cases as of Friday. The number of new cases continues to decrease, from an average of about 12 per day around the peak to fewer than one case per day recently, Chris Van Deusen, director of media relations at the Texas health department, told Reuters in an email. "The fact that (we) haven't had any new hospitalizations reported in more than two weeks gives us confidence there are not major numbers of unreported cases still occurring out there," said Van Deusen. The United States is battling one of the worst outbreaks of the highly contagious airborne infection it has seen, with over 1,000 reported cases and three confirmed deaths. Despite the slowing spread of the infection in Texas, the country continues to record weekly increases in measles cases elsewhere. The U.S. Centers for Disease Control and Prevention said a total of 1,168 confirmed measles cases were reported by 34 jurisdictions as of Thursday, an increase of 80 cases since its previous update last week. The only time infections surpassed the 1,000 mark was in 2019, when the country reported 1,274 cases. There have been 17 outbreaks, defined as three or more related cases, reported in 2025, the CDC said. Experts have urged public health officials to provide urgent endorsement for highly effective vaccines. The measles vaccine is 97% effective after two doses, according to the CDC.
NBC News
2 days ago
- NBC News
Texas woman dies from brain-eating amoeba after cleaning sinuses with tap water
A Texas woman died from an infection caused by a brain-eating amoeba days after cleaning her sinuses using tap water, according to a Centers for Disease Control and Prevention case report. The woman, an otherwise healthy 71-year-old, developed "severe neurologic symptoms" including fever, headache and an altered mental status four days after she filled a nasal irrigation device with tap water from her RV's water system at a Texas campsite, the CDC report said. She was treated for primary amebic meningoencephalitis (PAM) — a brain infection caused by Naegleria fowleri, often referred to as the"brain-eating amoeba,"the CDC said. Despite treatment, the woman experienced seizures and died from the infection eight days after she developed symptoms, the agency said. Lab tests confirmed the amoeba in the woman's cerebrospinal fluid, according to the report. The CDC said the infection usually occurs after "recreational water activities" but noted that cleaning sinuses with non-distilled water is also a risk factor for developing PAM. An investigation conducted by the agency found that the woman had not recently been exposed to fresh water but had done the nasal irrigation using non-boiled water from the RV's potable water faucet "on several occasions" before her illness. The potable water tank, the investigation found, was filled before the woman bought the RV three months ago and could have contained contaminated water. The investigation also concluded that the municipal water system, which was connected to the potable water system and bypassed the tank, could have caused the contamination. The agency stressed the importance of using distilled, sterilized or boiled and cooled tap water when performing nasal irrigation to reduce the risk of infection and illness.
Reuters
2 days ago
- Reuters
US COVID vaccine recommendations sow confusion among doctors, insurers
CHICAGO, June 5 (Reuters) - Health Secretary Robert F. Kennedy Jr.'s intervention in COVID-19 vaccine recommendations without input from a key U.S. CDC advisory panel has sown confusion among physicians and insurers over who should get the shots and whether they will be covered, experts told Reuters. Kennedy, a long-time vaccine skeptic, in a video posted on social media last week said the government was dropping its recommendation that healthy children and pregnant women should receive COVID shots. Days later, the Centers for Disease Control and Prevention updated its recommended childhood vaccine schedule online to show the shots could be given to healthy children when parents and doctors agree they are needed. It removed its recommendation that pregnant women should receive the shot. The moves sidestepped the normal process in which a panel of outside experts to the CDC - the Advisory Committee on Immunization Practices - reviews data in a public meeting and votes on vaccine recommendations. The ACIP recommendations are sent to the CDC director for approval and incorporated in the agency's vaccine schedule, which helps determine insurance coverage under the Affordable Care Act. "The surprise announcement has created uncertainty for payers and providers about whether the video posting constitutes an official policy change," said Sarah Moselle, a principal at health consultancy Avalere. Insurers will wait to make coverage decisions until after ACIP makes a recommendation at its upcoming meeting scheduled for June 25-27, according to Robert Popovian, founder of healthcare consultancy Conquest Advisors. The Department of Health and Human Services overseen by Kennedy said the move was within its legal and regulatory authority and reflects the agency's move toward clinical-guided decision making, a department spokesperson said. HHS will continue to rely on the work of expert panels, including ACIP, he said, noting that the committee will be meeting this month. The meeting agenda will be released in accordance with prior practice. Determinations on coverage are up to insurance providers, the spokesperson said. The CDC has previously recommended the COVID shot for everyone aged 6 months and older. "This whole thing is so murky," said an ACIP member who spoke on condition of anonymity. "It's very unclear whose decision is final." Infectious Diseases Society of America President Dr. Tina Tan said the conflicting COVID vaccine guidance could cause "significant confusion among medical professionals and the public." Dr. Matthew Zahn, an Orange County, California, public health official at OC Health Care Agency who serves as a liaison to the CDC's advisory panel, said: "We're all awaiting clarity." "It's going to be important to understand how these vaccines are insured," Zahn said. "Specifically, if ultimately there is a recommendation for high-risk populations to be vaccinated, how that is interpreted by insurance companies and thus, how providers can recommend it." Zahn expects CDC to clarify its guidance in the weeks ahead, though he could not comment on whether that will be at the ACIP meeting. On Tuesday, Reuters reported that pediatric infectious disease expert Dr. Lakshmi Panagiotakopoulos, a CDC official who helped oversee the expert panel on COVID vaccines, told colleagues she was leaving her post as she was "no longer able to help the most vulnerable members" of the U.S. population. The American College of Obstetricians and Gynecologists raised concerns on May 27 that the HHS decision not to recommend COVID vaccines during pregnancy would make it harder for pregnant women to get the shot "despite the clear and definitive evidence demonstrating its benefit." The Affordable Care Act generally requires insurers to cover vaccines that are listed on ACIP's vaccine schedule, according to the CDC's website. Narrowing coverage without knowing what ACIP recommends could put insurers at risk, Popovian said. "It's a liability," he said, adding that insurers need clarity on what they will be required to cover. A source familiar with plans for the meeting said the panel is expected to consider and vote on COVID-19 vaccines for the upcoming autumn and winter season, adding that the panel had been leaning toward narrowing its recommendations. The advisory panel has yet to receive an agenda for the upcoming meeting, the source said, and it is unclear whether Kennedy would override any deviation from his announced policy.
